Press release St. Louis Based Biotech Start-up Prevent-Plus Recognized as a 2021 Arch Grants Recipient Read More »
Clinical study New clinical data highlighting the clinical success and efficacy of Preventogen Read More »
Clinical article Prevention is the key—75,000 infection-related deaths and $33 Billion in costs Read More »
Press release Preventogen: One of the first FDA-cleared products shown to reliably kill urgent CDC threat Candida auris in a lab Read More »